Literature DB >> 23708674

Hemolytic uremic syndrome: an unusual complication of interferon-β treatment in a MS patient.

Elodie Nerrant, Mahmoud Charif, Anne-Sophie Ramay, Hélène Perrochia, Laure Patrier, Nicolas Menjot de Champfleur, Dimitri Renard, Pierre Labauge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23708674     DOI： 10.1007/s00415-013-6961-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

Review 1.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report.

Authors:  A Broughton; J-P Cosyns; M Jadoul
Journal:  Clin Nephrol       Date:  2011-11       Impact factor: 0.975

Review 3.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

4.  Nephrotic syndrome in a multiple sclerosis patient treated with interferon beta 1a.

Authors:  Anthony Auty; Abdulkarim Saleh
Journal:  Can J Neurol Sci       Date:  2005-08       Impact factor: 2.104

5.  Thrombotic microangiopathy associated with use of interferon-beta.

Authors:  Teresa Olea; Raquel Díaz-Mancebo; Maria-Luz Picazo; Jorge Martínez-Ara; Angel Robles; Rafael Selgas
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-06-15

6.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

Review 7.  Atypical hemolytic uremic syndrome.

Authors:  Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Orphanet J Rare Dis       Date:  2011-09-08       Impact factor: 4.123
  7 in total
  6 in total

1.  Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.

Authors:  Tatiana Koudriavtseva; Domenico Plantone; Rosaria Renna; Chiara Mandoj; Diana Giannarelli; Caterina Mainero
Journal:  Neurol Sci       Date:  2015-07-26       Impact factor: 3.307

Review 2.  Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.

Authors:  Maria Pia Amato; Emilio Portaccio
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

3.  Broad spectrum of interferon-related nephropathies-glomerulonephritis, systemic lupus erythematosus-like syndrome and thrombotic microangiopathy: A case report and review of literature.

Authors:  Iacopo Gianassi; Marco Allinovi; Leonardo Caroti; Lino Calogero Cirami
Journal:  World J Nephrol       Date:  2019-11-12

4.  A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review.

Authors:  Mosè Parisi; Alessia Manni; Francesca Caputo; Maria Trojano; Damiano Paolicelli
Journal:  Brain Behav       Date:  2020-12-16       Impact factor: 2.708

5.  Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab.

Authors:  Marco Allinovi; Calogero Lino Cirami; Leonardo Caroti; Giulia Antognoli; Silvia Farsetti; Maria Pia Amato; Enrico Eugenio Minetti
Journal:  Clin Kidney J       Date:  2017-02-16

6.  Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review.

Authors:  Maxime Dauvergne; David Buob; Cédric Rafat; Marie-Flore Hennino; Mathilde Lemoine; Vincent Audard; Dominique Chauveau; David Ribes; Emilie Cornec-Le Gall; Eric Daugas; Evangéline Pillebout; Vincent Vuiblet; Jean-Jacques Boffa
Journal:  Clin Kidney J       Date:  2021-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.